STOCKHOLM — The phone calls went out from Sweden in the small hours of the morning, and at least one of them woke a man half asleep. Karl Deisseroth, a neuroscientist at Stanford, had been up late finishing a paper and was just drifting off when the committee rang his bedside phone.
“My phone rang at my bedside. There was about 30 seconds when I had trouble forming words,” he told reporters later.
He had just won the 2026 Nobel Prize in Physiology or Medicine.
Deisseroth, 54, shares the prize with two German scientists — Peter Hegemann, 71, of Humboldt University in Berlin, and Georg Nagel, 73, of the University of Würzburg. The Nobel Assembly at Sweden’s Karolinska Institute announced the award on Monday, honoring the trio “for discoveries concerning light-gated ion channels and optogenetics.” The three will split 12 million Swedish kronor, roughly $1.2 million.
A pond alga and a wild idea
The story starts, improbably, with a single-celled alga. In the early 1990s, Hegemann was trying to work out how Chlamydomonas, a microscopic pond organism, swims toward light. He suspected the answer was one protein doing two jobs at once — detecting light and acting as a channel that lets charged particles flow through.
Teaming up with Nagel, then at the Max Planck Institute in Frankfurt, he proved it. By injecting the alga’s genes into frog eggs, they isolated the protein — channelrhodopsin-2 — a tiny switch that snaps open when struck by light. In 2003 the pair showed the protein could be placed in human and hamster cells to fire electrical impulses on command, using only light.
“They had just discovered the switch neuroscientists had long dreamed of,” said Abdel El Manira, a member of the Nobel committee, during the announcement.
But it was Deisseroth who turned the discovery into a revolution. At Stanford, he genetically engineered nerve cells to produce channelrhodopsin, then switched those cells on and off simply by shining light on them. The 2005 result — precise control of individual neurons in a living brain — gave neuroscience the tool it had awaited for decades. A year later, the technique got its name: optogenetics.
A remote control for the brain
Optogenetics works, in essence, like a remote control for the brain. Scientists insert the gene for a light-sensitive protein into specific nerve cells, then deliver pulses of light — usually through a thin fiber-optic cable — to flip those cells on or off with millisecond precision.
As committee secretary-general Thomas Perlmann put it, researchers can now “switch on, or off, the activity of individual nerve cells in a living brain.” The method is now used in laboratories worldwide to map which circuits produce memories, emotions, and behavior — questions once unapproachable.
“It’s a tremendous step forward to be able to link nerve cells and their function to specific behaviours,” said committee member Anna Wedell. “It’s a completely new dimension of understanding of the function of the brain.”
The clinical horizon is opening: optogenetic approaches have entered early-stage human trials, though researchers stress the field is still young. Nagel himself thought the prize was premature: “I didn’t expect this, really!” he said, having taken the call on a sunlit terrace in Italy. “I always told them ‘Keep cool.'”
Why this matters
The brain is the least understood organ we own, and its disorders are among the cruelest. Depression, schizophrenia, epilepsy, Parkinson’s — for all of them, doctors have mostly worked in the dark, treating symptoms with drugs and electrical stimulation without knowing exactly which circuits misfire. Optogenetics didn’t just hand researchers a sharper tool; it changed the questions they can ask. Instead of asking which brain regions happen to light up during a behavior, scientists can now ask what happens when they switch a single circuit on — or off. That move from correlation to causation happens once in a generation — which is why so many neuroscientists saw this prize coming years ago. The method still lives mostly in animal laboratories, and the road to human therapy is long and uncertain. But every future treatment that tunes a diseased brain circuit will trace back to a pond alga and three scientists who followed a strange hunch.
What comes next
The medicine prize traditionally opens Nobel week. The physics prize follows on Tuesday, chemistry on Wednesday, literature on Thursday, and the peace prize on Friday, with the economics prize closing the season on October 12. All 2026 laureates will collect their medals and diplomas at the award ceremony in Stockholm on December 10.
